Skip to main content
TipRanks
Go Ultimate75% OFF

IRLAB Therapeutics AB Class A (6IRA) Cash flow

1 Followers

IRLAB Therapeutics AB Class A Cash Flow

DE:6IRA's free cash flow for Q2 2026 was kr-13.45M. For the 2026 fiscal year, DE:6IRA's free cash flow was increased by kr0.00 and operating cash flow was kr-13.45M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
kr -55.22Mkr -65.59Mkr -164.85Mkr -142.61Mkr 128.64M
kr 0.00kr -199.00Kkr -293.00Kkr -3.38Mkr -708.00K
kr 73.41Mkr 21.40Mkr 23.68Mkr -3.13Mkr -3.04M
kr 81.86Mkr 66.92Mkr 111.31Mkr 252.78Mkr 401.90M
kr -55.22Mkr -65.79Mkr -165.14Mkr -145.99Mkr 127.93M

Currency in SEK

IRLAB Therapeutics AB Class A Cash Flow

-200M-100M0100M200M300M201720182019202020212022202320242025OperatingInvestingFinancing